Edition:
India

Charles River Laboratories International Inc (CRL.N)

CRL.N on New York Stock Exchange

99.98USD
18 Aug 2017
Change (% chg)

$0.27 (+0.27%)
Prev Close
$99.71
Open
$99.43
Day's High
$100.39
Day's Low
$98.90
Volume
69,284
Avg. Vol
79,054
52-wk High
$102.23
52-wk Low
$67.21

CRL.N

Chart for CRL.N

About

Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its... (more)

Overall

Beta: 0.99
Market Cap(Mil.): $4,758.43
Shares Outstanding(Mil.): 47.59
Dividend: --
Yield (%): --

Financials

BRIEF-Charles River Laboratories posts Q2 adj. earnings $1.29/shr

Aug 9 Charles River Laboratories International Inc

09 Aug 2017

BRIEF-Charles River Laboratories acquires Brains On-Line

Aug 7 Charles River Laboratories International Inc

07 Aug 2017

BRIEF-Charles River Laboratories' Board increase size of board from nine to ten

July 6 Charles River Laboratories International Inc

06 Jul 2017

BRIEF-Spago Nanomedical signs deal with Charles River Laboratories for preclinical studies

* ANNOUNCE AGREEMENT WOTH CHARLES RIVER LABORATORIES FOR PRECLINICAL STUDIES Source text for Eikon: Further company coverage: (Gdynia Newsroom)

08 Jun 2017

BRIEF-Charles River Laboratories reports updates to oncology business

May 16 Charles River Laboratories International Inc:

16 May 2017

BRIEF-Charles River Laboratories reports Q1 non-GAAP earnings per share $1.29

May 10 Charles River Laboratories International Inc:

10 May 2017

BRIEF-Nimbus Therapeutics enters strategic partnership with Charles River Laboratories

April 5 Charles River Laboratories International Inc:

05 Apr 2017

Earnings vs. Estimates